Meytal Neeman-Azulay results 2
· Newest (Page 1/1, per page 25)
Author: Meytal Neeman-Azulay ×Clear All Filters
Search Results
Seven-year experience (2018–2025) of a hospital-based cardiovascular tissue bank in Israel: operational insights and clinical impactNARA Subscribed
Cryopreserved human heart valves and cardiovascular tissues (homografts) are essential for the surgical treatment of congenital and acquired valvular diseases, particularly in pediatric patients, where prosthetic options are limited. To address the clinical demand for high-quality grafts in Israel, Sheba Medical Center, the largest tertiary care hospital in Israel, established a Good Manufacturing Practice (GMP) compliant Card...
Comparing the efficacy of two antibiotic cocktails in decontamination of cardiovascular tissuesNARA Subscribed
Cardiovascular allografts are essential for patients with severe cardiovascular diseases. Yet, microbial contamination of the grafts poses a life-threatening risk to recipients. Tissue banks utilize various decontamination methods during cardiovascular tissue processing, often involving antibiotic solutions. This study compares the efficacy of an in-house prepared antibiotic cocktail (tissue bank cocktail) and a commercially a...
Previous1Next